Arthur Santora Net Worth

Arthur Santora biography

Dr. Arthur C. Santora serves as Chief Medical Officer of the Company. Dr. Santora has more than 30 years of experience in the biopharmaceutical industry. He spent the majority of his career in the clinical research team at Merck & Co., Inc., from June 1989 to March 2017, where he was the lead clinical research physician responsible for much of the clinical development of Fosamax® (alendronate sodium), one of the world’s most prescribed osteoporosis treatments. He was closely involved in the clinical development of Merck’s once-weekly Fosamax Plus D (alendronate sodium/ vitamin D3 combination tablets), the first drug/vitamin combination tablet in the US. His position at Merck immediately prior to his termination of services in 2017 was Scientific Associate Vice President of Clinical Research, where he was directly responsible for the technical and scientific support for all clinical research of Fosamax/Fosamax plus D and contributed to the development of many other osteoporosis and endocrine marketed and investigational drugs. Prior to joining Merck, he served as a Medical Officer at the US FDA and subsequently was a faculty member at Wayne State University Medical School in Detroit. Dr. Santora is a Clinical Associate Professor at the clinical faculty of Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey. He has graduate training in Internal Medicine at Emory, and its Endocrinology and Metabolism subspecialty at the NIH in Bethesda. Dr. Santora received his M.D. and Ph.D. in biochemistry from Emory University in Atlanta.

What is the salary of Arthur Santora?

As the Chief Medical Officer of Entera Bio Ltd, the total compensation of Arthur Santora at Entera Bio Ltd is $445,479. There are 2 executives at Entera Bio Ltd getting paid more, with Phillip Schwartz having the highest compensation of $722,014.

How old is Arthur Santora?

Arthur Santora is 69, he's been the Chief Medical Officer of Entera Bio Ltd since 2018. There are 3 older and 14 younger executives at Entera Bio Ltd. The oldest executive at Entera Bio Ltd is Gerald Lieberman, 73, who is the Independent Chairman of the Board.

What's Arthur Santora's mailing address?

Arthur's mailing address filed with the SEC is KIRYAT HADASSAH,, MINRAV BUILDING, 5TH FLOOR, JERUSALEM, L3, 9112002.

Insiders trading at Entera Bio Ltd

Over the last 3 years, insiders at Entera Bio Ltd have traded over $0 worth of Entera Bio Ltd stock and bought 467,822 units worth $484,536 . The most active insiders traders include Gerald M Lieberman, Miranda Jayne Toledano, and Sean Ellis. On average, Entera Bio Ltd executives and independent directors trade stock every 32 days with the average trade being worth of $36,205. The most recent stock trade was executed by Haya Taitel on 12 January 2024, trading 9,500 units of ENTX stock currently worth $9,405.

What does Entera Bio Ltd do?

entera bio ltd. is a biotechnology company located in israel.

Entera Bio Ltd executives and stock owners

Entera Bio Ltd executives and other stock owners filed with the SEC include:

• Phillip Schwartz,
  President of Research and Development
• Gerald Lieberman,
  Independent Chairman of the Board
• Arthur Santora,
  Chief Medical Officer
• Dr. Phillip Schwartz Ph.D.,
  Exec. VP, Pres of R&D and Director
• Roger Garceau,
  Chief Executive Officer, Director
• Hillel Galitzer,
  Chief Operating Officer
• Dr. Hillel Galitzer,
  Chief Operating Officer
• Dr. Arthur C. Santora II, M.D., Ph.D.,
  Chief Medical Officer
• Kiryat Hadassah,
  IR Contact Officer
• Miranda Toledano,
  Independent Director
• Gerald Ostrov,
  Independent Director
• Faith Charles,
  Independent Director
• Yonatan Malca,
  Director
• Sean Ellis,
  Director
• Zeev Bronfeld,
  Director
• Jonathan Lieber,
  Chief Financial Officer - U.S.-based
• Dana Yaacov-Garbeli,
  Chief Financial Officer
• Dr. Roger J. Garceau,
  Chief Devel. Advisor & Director
• Ramesh Ratan,
  U.S. Chief Financial Officer
• Dana Yaacov-Garbeli CPA,
  Chief Financial Officer
• Dr. Spiros Jamas,
  CEO & Director
• Haya Taitel,
  Director
• Ramesh Ratan,
  U.S.based CFO
• Spiros Jamas,
  Chief Executive Officer
• Ron Mayron,
  Director